Why a Selank dosage on a foreign label does not travel
That number is real. It is also the least transferable thing about the situation, and the confidence it lends to every figure circulating in English is entirely borrowed. There is no FDA, EMA or MHRA authorisation, no Western label, and no genuine registered Western trial to produce one.
A label is not a fact about a molecule. It is a decision about a product, and it carries four conditions that all have to hold for the number to mean what it says.
It applies to a specific manufactured preparation, made to a defined standard, at a verified strength, by a route that was tested. Change the preparation and the number stops describing anything. It applies to an approved indication, meaning the amount was set for a defined problem in a defined group of people. It presumes a prescriber who diagnosed that problem and who is accountable for the decision. And it sits inside a system with pharmacy dispensing, oversight and a route for reporting harm.
An online buyer in Chicago or Leeds has none of those four. The vial was made by an unknown party to no agreed standard, with contents nobody has verified. There is no diagnosis, no approved indication and no accountable prescriber. Taking a number that depends on all four conditions and applying it where none of them holds is not a cautious use of good evidence. It is the appearance of good evidence with the substance removed.
Where the numbers circulating in English came from
Trace almost any confident figure in English and it lands in one of the bottom four rows, often having passed through the top one at some point and lost every condition attached to it along the way. That laundering is quiet and it is the reason a number can look authoritative while resting on nothing you could check.
| Source of a figure | How it arose | Organism behind it | What it can actually carry |
|---|---|---|---|
| The Russian approved label | Regulatory review of a specific product | Human, inside that system | That product, that indication, that setting |
| Animal research | Amounts chosen for an experiment | Rat and mouse | Nothing about a human amount |
| Forum consensus | Repetition until it sounded standard | None | The confidence of whoever repeated it last |
| Seller convention | Vials filled at a convenient strength | None | A manufacturing decision, working backwards |
| Clinic protocols | A provider's estimate from the above | Mixed and usually unstated | A judgment, not a tested range |
What a consultation genuinely changes
Some of what a clinic offers is worth paying for and this site has no interest in pretending otherwise. A qualified person can identify a condition that makes the whole idea unwise. They can review what else you take, which matters for anything acting on mood or the nervous system. They can ask whether an anxiety complaint has a cause that deserves investigation rather than a compound. They can arrange baseline bloodwork and be reachable if something goes wrong. They carry professional responsibility for the encounter.
What no consultation can do is create a locally valid amount for an unapproved product. A clinician in a country where this peptide is unapproved has no local label to prescribe from, no verified product to prescribe, and no Western trial data to reason from. They can read the same public information you can. Where the number comes from is a question they should be able to answer, and the honest answer is that it is an estimate.
This is where a professional setting lends authority the evidence has not paid for. A consulting room, a printed plan and a qualification are strong signals that a figure came from an established process. The signal is doing work here that the underlying situation does not support, and it is at its most convincing when the clinician is entirely sincere and simply repeating what the field repeats.
What disappears when the label stays behind the border
Strip away the paperwork and several protections vanish at once, each of which a licensed buyer receives without noticing.
Verified identity and strength disappear, so any calculation rests on a supplier's word about what is in the container. The approved indication disappears, so nobody with authority has agreed what the substance is for. The list of known harms disappears, because that list is assembled from collected human data inside a regulated system rather than from customer messages. The recall route disappears, so nothing can find you if a batch is wrong. The reporting system disappears, so a pattern of harm across many buyers has nowhere to accumulate.
Liability disappears too, or rather it moves. In a licensed chain a manufacturer answers for the contents of the container. Outside it, the risk sits entirely with the person holding the vial, and the research use disclaimer on the seller's page exists to make that transfer explicit.
That last point deserves its own sentence. Many suppliers state the product is not for human consumption while the same site describes how people use it. Only one half of that is enforceable, and it is not the half describing use.
The unit problem nobody warns about
There is a mechanical hazard sitting underneath the evidence question, and it is the one most likely to cause immediate harm.
Amounts for peptides get quoted in different units on different pages, and the same figure can appear as micrograms in one place and milligrams in another. A licensed product removes this problem entirely: the strength is stated, verified and printed on the container, and a pharmacist has handled the preparation. An online purchase reinstates it. The buyer is often reconstituting a powder themselves, calculating a concentration from a strength nobody has confirmed, and drawing from it with a syringe marked in units that were designed for something else.
Every one of those steps is a place where a factor of ten can enter unnoticed. The arithmetic is not difficult, and that is precisely why it gets done casually, at home, from a forum post, with no second person checking it and no label to check against.
This is a risk with no relationship to whether the compound works. It exists because the entire apparatus that normally keeps a quantity correct, from verified strength through pharmacy dispensing to a label, has been removed and replaced by a customer with a calculator.
The reason this case is genuinely harder than most
With most compounds sold this way the sceptical position is easy, because there is nothing behind the claims but animal work. Here there is something behind them. Human clinical work exists in Russia, the registration is real, and dismissing it would be inaccurate.
The difficulty is that the evidence and the product have been separated. The evidence lives in one system, attached to a licensed preparation, published largely in a language most buyers cannot read and not indexed alongside the trial records they can search. The product lives in another system with no verification at all. Marketing moves the credibility across the gap without moving anything else, and a truthful sentence about approval does most of the work.
A useful discipline is to ask which object a claim is about. A statement about the compound as used in Russia may be well founded. The same statement applied to a vial from a website is about a different object entirely, and no evidence in the world covers it.